Amneal Pharmaceuticals (AMRX) Inventory (2017 - 2026)

Amneal Pharmaceuticals' Inventory history runs 10 years deep, the most recent figure standing at $641.6 million for Q1 2026.

• In Q1 2026, Inventory rose 6.68% year-over-year to $641.6 million; the TTM figure through Mar 2026 stood at $641.6 million (up 6.68% YoY), while the FY2025 annual figure was $606.3 million, down 1.0% from the prior year.
• Inventory was $641.6 million for Q1 2026 at Amneal Pharmaceuticals, up from $606.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $641.6 million in Q1 2026 to a low of $512.2 million in Q1 2022.
• Historically, Inventory has averaged $575.6 million across 5 years, with a median of $576.5 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Inventory climbed 9.54% in 2023, then decreased 1.0% in 2025.
• A 5-year view of Inventory shows it stood at $530.7 million in 2022, then grew by 9.54% to $581.4 million in 2023, then rose by 5.34% to $612.5 million in 2024, then dropped by 1.0% to $606.3 million in 2025, then gained by 5.82% to $641.6 million in 2026.
• The last three Inventory figures came in at $641.6 million (Q1 2026), $606.3 million (Q4 2025), and $614.5 million (Q3 2025), per Business Quant data.